G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01) C12Q 1/48 (2006.01)
Patent
CA 2655851
The present invention relates to the assessment of lung cancer. It discloses the use of protein NNMT in the assessment of lung cancer. It also relates to a method for assessing lung cancer by measuring NNMT in vitro in a liquid sample derived from an individual. Measurement of NNMT can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.
La présente invention concerne l'évaluation du cancer du poumon. Elle concerne l'utilisation de la protéine NNMT pour l'évaluation du cancer du poumon. Elle concerne également un procédé permettant d'évaluer le cancer du poumon en mesurant la NNMT in vitro dans un échantillon liquide prélevé sur un individu. La mesure de la NNMT peut notamment être utilisée pour la détection précoce ou le suivi de patients atteints d'un cancer du poumon.
Hagmann Marie-Luise
Karl Johann
Kott Theresa
Roessler Markus
Rollinger Wolfgang
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Use of nnmt as a marker for lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nnmt as a marker for lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nnmt as a marker for lung cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1778059